Back to Archived News
New Leadership and Breakthrough Therapeutics Are Focus of Two-Day Conference on Biotechnology, Life Sciences and Specialty Pharmaceuticals
Wednesday, April 04, 2007
New York, NY -- Executives from more than 80 public and private healthcare companies, along with physicians, investors, and analysts are attending the CIBC World Markets Annual Biotechnology and Specialty Pharmaceuticals Conference, April 11-12, 2007, at New York's Millennium Broadway Hotel.
The highly anticipated conference will feature key insights into recent developments in oncology, cardiovascular, auto-immune disorders, CNS/pain and infectious diseases from leading mid and small cap companies in biotechnology, life sciences and specialty pharmaceuticals. There will also be a panel discussion on the diabetes and obesity epidemic, with leading authorities in the field: F. Xavier Pi-Sunyer, MD, MPH; Stephen B. Richardson, F.A.C.P., F.RC.P; and Jay S. Skyler, MD, MACP. The panel discussion will focus on new and current treatments of type 2 diabetes, as well as the overall landscape for diabetes drug development.
More information on the conference including presenting companies and an agenda can be found at: http://conferences.cibcwm.com/biotech07/
Important note about media attendance:
This event is by invitation only; Media wishing to attend are required to register in advance by calling (416) 980-4048. This event will also be available via webcast at http://conferences.cibcwm.com/biotech07/ (enter code: april07).
CIBC World Markets is the wholesale and corporate banking arm of CIBC, providing a range of integrated credit and capital markets products, investment banking, and merchant banking to clients in key financial markets in North America and around the world. We provide innovative capital solutions and advisory expertise across a wide range of industries as well as top-ranked research for our corporate, government and institutional clients.
Back to Archived News
